Study S001251

Evaluation of Insulin Glargine and Exenatide: A Randomized Clinical Trial With Continuous Glucose Monitoring and Ambulatory Glucose Profile Analysis

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01089569
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: COMPLETED
Enrollment: 60
Start: 2010-04
Primary completion: 2013-05
Lead sponsor: HealthPartners Institute
Conditions: Type 2 Diabetes
Interventions: DRUG:Exenatide; DRUG:Insulin Glargine
Results posted: TRUE
Individual participant data sharing: NO

Registered primary outcomes

HbA1c Change [baseline to final visit (32 weeks)]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0027318	Diurnal glucose patterns of exenatide once weekly: a 1-year study using continuous glucose monitoring with ambulatory glucose profile analysis. Mazze R, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists	2009	Other trial	PMID 19454385 DOI	registry reference BACKGROUND:19454385